Claudia Gonzaga-Jauregui

Title: Innovator Spotlight: Claudia Gonzaga-Jauregui

Introduction: Claudia Gonzaga-Jauregui is a notable inventor based in Tarrytown, NY, with a remarkable portfolio of 7 patents. Her innovative work primarily focuses on developing genetically modified rodent models for studying various human diseases, contributing significantly to the fields of genetics and disease research.

Latest Patents: Among her impressive patents, two stand out for their groundbreaking implications. The first is a genetically modified rodent model designed to study skin inflammation disorders, such as psoriasis. This rodent carries a loss of function mutation in the endogenous Crnn (cornulin) gene. The second patent relates to a rodent model for mood disorders, including unipolar depression and anxiety. This model features a humanized G protein-coupled receptor 156 (GPR156) gene, encoding a mutant protein crucial for understanding these complex disorders.

Career Highlights: Claudia has spent significant time at prominent biotechnology firms, including Regeneron Pharmaceuticals, Inc., where she has been instrumental in advancing research initiatives. Her experience has equipped her with both the technical knowledge and practical insights necessary for impactful innovations in biomedical research.

Collaborations: During her career, Claudia has collaborated with esteemed colleagues, such as Kavita Praveen and Chia-Jen Siao. These professional relationships have fostered a collaborative environment that encourages the sharing of ideas and fosters innovative solutions in their field.

Conclusion: Claudia Gonzaga-Jauregui represents the spirit of innovation in biomedical research. Through her extensive patent portfolio and collaboration with leading professionals, she continues to make significant strides in the understanding of complex diseases, paving the way for future therapies and treatments.